Unit
- Biomarker definition: A biological molecule found in blood, body fluids, or tissues that indicates a normal or abnormal process, or a condition or disease. Biomarkers can be DNA, RNA, protein, or metabolite based and must be objectively measured and evaluated.
- Clinical applications: Biomarkers serve diagnostic, prognostic, predictive, and monitoring roles. For example, elevated prostate-specific antigen (PSA) suggests prostate cancer risk, while HER2 status guides trastuzumab therapy in breast cancer.
- Precision medicine context: Biomarker testing enables targeted therapies, reducing trial-and-error prescribing and improving patient outcomes. It underpins the shift from one-size-fits-all to individualized treatment plans.
- Regulatory recognition: The FDA and other health authorities define biomarker categories and qualification pathways. A qualified biomarker is one with established analytical and clinical validity for a specific context of use.
- Operational impact: Laboratories must validate assays for accuracy, precision, and reproducibility. Testing operations require standardized pre-analytical, analytical, and post-analytical procedures.
- Stakeholder alignment: Clinicians, laboratorians, regulatory affairs, and IT teams collaborate to select appropriate biomarkers and implement testing workflows. Clear communication ensures clinical utility and operational feasibility.
- Economic considerations: Biomarker testing can reduce overall healthcare costs by avoiding ineffective treatments. However, upfront validation and equipment investment require careful financial planning.
- Ethical boundaries: Genetic biomarker testing raises privacy, informed consent, and data protection concerns. Operational policies must address incidental findings and patient rights.
- Sample types and handling: Common biomarker sample types include blood (plasma, serum), tissue biopsies, cerebrospinal fluid, and urine. Each type requires specific collection, processing, and storage protocols to preserve analyte integrity. Preanalytical variables such as hemolysis, temperature, and time to processing can significantly affect results.
- Assay technology platforms: Biomarker testing utilizes various platforms including ELISA, PCR, next-generation sequencing (NGS), mass spectrometry, and immunohistochemistry. Selection depends on biomarker type, required sensitivity, throughput, and laboratory capabilities. Each platform has distinct validation requirements and quality control metrics.
- Data management and reporting: Operations managers oversee the secure handling, storage, and transfer of biomarker data. This includes integrating results into electronic health records, generating standardized reports, and ensuring traceability. Data integrity and audit trails are critical for regulatory compliance and clinical decision-making.
- Continuous quality improvement: Ongoing monitoring of assay performance through proficiency testing, internal quality controls, and corrective action plans is essential. Operations managers implement root cause analysis for deviations and coordinate updates to standard operating procedures to maintain high-quality testing.
Scope of Practice
Role: Biomarker Testing Operations Manager
Within scope:
- Overseeing assay validation and quality control procedures
- Coordinating sample handling and chain of custody documentation
- Managing turnaround times and reporting workflows
- Ensuring compliance with CLIA and CAP standards
Outside scope:
- Interpreting clinical results or making diagnostic recommendations
- Performing laboratory testing or operating analytical instruments
- Treating patients or prescribing therapies based on results
- Authorizing test orders or selecting specific assays for patients
Quick Revision
- Biomarkers are measurable biological indicators used for diagnosis, prognosis, prediction, and monitoring.
- Precision medicine relies on validated biomarker testing to guide targeted therapies.
- Operational managers coordinate validation, quality, and compliance but do not interpret results or treat patients.